Navigation Links
AbbVie Reports Second-Quarter 2014 Financial Results
Date:7/25/2014

t of that element of the consideration provided to them in the form of shares in New AbbVie, but that any cash consideration received by such shareholders for their Shire Shares will crystallise a disposal for such shareholders for the purposes of UK tax on chargeable gains and may, depending on the circumstances of such shareholders, give rise to a charge to UK capital gains tax or UK corporation tax.It is expected that, for U.S. federal income tax purposes, the Transaction generally will be taxable to U.S. shareholders of both AbbVie and Shire. The tax consequences of the Transaction may vary based on an individual shareholder's circumstances, and a more complete description of the anticipated tax consequences of the Transaction will be made available in the Scheme Circular and the AbbVie Proxy Statement.This information is intended to be general guidance only and does not take into account individual investors' specific circumstances or constitute tax advice to any investor.  Investors who require further information about the tax consequences of the transaction are urged to seek tax advice from appropriately qualified tax advisors.   

Schedule 1
Profit Forecast for AbbVie Inc for the Financial Year ended December 31, 2014 and for three months ended September 30, 2014In accordance with Rule 28.4(a) of the Code, the principal assumptions upon which the profit forecast is based are included in this Schedule 1 to the announcement. In accordance with Rule 28.4(b) of the Code, there is a clear distinction made between assumptions which the Directors of AbbVie (or other members of AbbVie's management) can influence and those which they cannot influence.

1.
GeneralAbbVie today made the following statements in its Second-Quarter 2014 Financial Results Announcement:

Full-Year 2014 Outlook

Excluding the potential impact of the transaction with Shire, AbbVie is confirming its recently-increased diluted
'/>"/>

SOURCE AbbVie
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. AbbVie to Host Second-Quarter Earnings Conference Call
2. AbbVie to Host Fourth-Quarter and Full-Year 2013 Earnings Conference Call
3. AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C
4. AbbVie Releases First of Six Phase III Results from Investigational All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients New to Therapy
5. U.S. Gastroenterologists Have Increased Their TNF-alpha Inhibitor Use Since 2012, Especially for AbbVies Humira, as a Result of Its Recent Approval in Ulcerative Colitis
6. Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte
7. AbbVie Reports Third-Quarter 2013 Financial Results
8. AbbVie Named a Science Top Employer
9. AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
10. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
11. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
(Date:1/23/2015)...  HyGreen, Inc., a leader in hand hygiene monitoring, today ... a subsidiary of Ascendis Health Limited, in ... hundreds of millions of patients around the world are ... from patient to patient via the unwashed hands of ...
(Date:1/23/2015)... 2015  iMD Companies, Inc. (ICBU) has repositioned itself as a ... grab a foothold in the hydroponic, hemp and medical marijuana ... presence in the sector, and recently partnering with the Chippewa ... and medical marijuana, iMD is committing to bring its vision ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... is pleased to announce that its InsightCS® Revenue Cycle ... Behavioral HealthCare (UBHC) with more than 800 users at ... UBHC, a division of the University of Medicine ... InsightCS® system,s complete, end-to-end Patient Access (Registration, Scheduling, ADT) ...
...   Curemark LLC , a Rye, New York-based drug ... III double blind randomized placebo controlled multicenter clinical trial ... endpoints.  The trial compared CM-AT to placebo in children ... demonstrate a statistically significant effect of CM-AT over placebo ...
Cached Medicine Technology:University Behavioral HealthCare Goes Live with Stockell Healthcare Systems' InsightCS® Revenue Cycle Information Management System 2Curemark LLC Reports Positive Phase III Results of CM-AT in Children With Autism 2Curemark LLC Reports Positive Phase III Results of CM-AT in Children With Autism 3
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television host, ... 32nd Annual Miami Breast Cancer Conference planned and ... , shares that “a fast-growing, virulent” cancer in her ... not followed up her clean mammogram with an ultrasound. ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
(Date:1/22/2015)... WASHINGTON, DC (PRWEB) January 22, 2015 ... conditions in vulnerable communities and cause financial distress to ... report by analysts at Howard University’s Center on Race ... of dollars in economic activity, payday loans at the ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... Hormone Therapy Recommendations Evidence of significant ... to issue recommendations against using estrogen plus progestin in ... conditions. To update its recommendations, the Task Force conducted ... determine the effectiveness of HRT in reducing risks for ...
... controlling glucose (glycemic) levels in type-2 diabetes patients may not ... a review of data from seven clinical trials, is published ... Medicine . To test the hypothesis that aggressive ... 2 diabetes mellitus, first author Steven G. Coca of Yale ...
... HealthDay Reporter , FRIDAY, May 25 (HealthDay News) -- ... doubled since 1994, researchers report, and the obesity epidemic is ... 11 Americans now develops kidney stones, according to scientists from ... contrast, only one in 20 Americans developed kidney stones back ...
... , SUNDAY, May 27 (HealthDay News) -- ... a new, small study says. Swedish researchers followed ... grade, for nine years. Some children were assigned to ... a week, plus extra training in motor-physical skills such ...
... , FRIDAY, May 25 (HealthDay News) -- Scientists say ... much better than the bland supermarket variety. The ... tomato samples representing 152 heirloom varieties, most of which ... tomatoes had an unexpectedly large chemical diversity. ...
... By Dennis Thompson HealthDay Reporter , FRIDAY, May ... kids suffering severe emotional turmoil find relief in physical pain ... achieve a form of release. But researchers now are ... these young people and help them before they do themselves ...
Cached Medicine News:Health News:Embargoed news from Annals of Internal Medicine 2Health News:As Obesity Rates Rise, Cases of Kidney Stones Double: Study 2Health News:As Obesity Rates Rise, Cases of Kidney Stones Double: Study 3Health News:More Mental Health Care Urged for Kids Who Self-Harm 2Health News:More Mental Health Care Urged for Kids Who Self-Harm 3
... with the skin to ... field. In addition to ... effect, HIBICLENS' non-drying, low ... compliance with the frequent ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... multi-purpose topical gel contains 10% Povidone Iodine ... action. As a pre-operative prep, Povidone Iodine ... prepping solutions under the patient, thus reducing ... is also approved as a one step ...
Medicine Products: